Sionna Therapeutics (SION) Assets Average (2025 - 2026)
Quarterly results put Assets Average at $315.5 million for Q1 2026, up 13.61% from a year ago — trailing twelve months through Mar 2026 was $315.5 million (up 13.61% YoY), and the annual figure for FY2025 was $255.9 million, changed.
Sionna Therapeutics has reported Assets Average over the past 2 years, most recently at $315.5 million for Q1 2026.
- Assets Average reached $315.5 million in Q1 2026 per SION's latest filing, down from $332.6 million in the prior quarter.
- Across five years, Assets Average topped out at $360.9 million in Q2 2025 and bottomed at $277.7 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 40.71 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 26.03 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Sionna Therapeutics | 1.87 Bn | 1.87 Bn | - | 315.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 315.50 Mn |
| Dec 31, 2025 | 332.61 Mn |
| Sep 30, 2025 | 345.66 Mn |
| Jun 30, 2025 | 360.86 Mn |
| Mar 31, 2025 | 277.71 Mn |